Ian W. Flinn, MD, PhD; Shaji Kumar, MD; and Farhad Ravandi, MD, discuss important presentations in hematologic malignancies from the virtual ASCO 2020 as reported by Clinical Care Options (CCO)
Commentary from Danielle M. Brander, MD, on the importance of prognostic testing of key markers in patients with CLL, as reported by Clinical Care Options (CCO)
Prof. Brümmendorf provides his thoughts on treatment-free remission for patients with CML who achieve a complete molecular remission with TKI therapy
Latest evidence on effective management of chronic lymphocytic leukemia (CLL) using BTK inhibitors in this video from Clinical Care Options (CCO)
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.